Nicole Dale

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

Read The Cursed Little Black Box of the AI Algorithm
- AI Drug Discovery
- AI Drug Development
- Machine Learning in Pharma
- LLMs in Pharma
- AI & Machine Learning
- AI and Automation
- AI governance
- Computational Biology
- Research Informatics
- Multiomics
- Biomedical R&D
- Preclinical Development
- Translational & Pre-clinical Research
- Laboratory Quality
- Translational Science and Biomarkers
- Non-Animal Testing
- Nonclinical Development
- The Discovery Loop
- Genetics & Molecular Biology
- Drug Targets
- Target Identification
- Target Validation
- Patient Registries
- Data Quality
- Data Analysis
- Research Funding
- Research Data
- Drug Discovery
- biomarkers
- Pharma Policy
- Pharma Regulation
- Regulatory & IP
- Data Integrity
- Data Management
- AI vendor auditing
- AI vendor assessment
The Cursed Little Black Box of the AI Algorithm
Read FDA’s NAIN Programme for Alzheimer’s Prevention
- FDA
- Neurological Disease
- Pharma Regulation
- Clinical Trial Regulation
- Clinical Trial Design
- Clinical Trial Strategy
- clinical trials
- Adaptive Clinical Trials
- Clinical Data
- Clinical Evidence
- Clinical Logistics
- Clinical Outcomes
- Clinical Trial Recruitment
- Clinical Research Organisations
- Mental Health
- Pharma Policy
- Global Regulatory Affairs
- Regulatory Consultation
- Regulatory Pathways
- Regulatory Submissions
- Regulatory Strategy
- Patient Registries
- Biomedical R&D
- biomarkers
- Translational Science and Biomarkers
- Medical Imaging
- Diagnostics
- Patient Enrolment
- Patient Centricity and Outcomes
- patient stratification
- Biostatistics
- Next-gen Modalities
- Preventative Care
- Preventative Medicine
- Medical Devices
- Commercialisation & Medical Affairs
- Biologics
- Deep Longevity
- Longevity
- biological age
- Biological Ageing
FDA’s NAIN Programme for Alzheimer’s Prevention
Read Night of the Living Drug: The Mortuary of Molecules Has Come Alive!
- Drug Discovery
- The Discovery Loop
- Commercial Strategy
- Computational Biology
- AI Drug Development
- AI Drug Discovery
- AI & Machine Learning
- Machine Learning in Pharma
- Pharma Intelligence
- Biomedical R&D
- AI Pharma
- LLMs in Pharma
- Genetics & Molecular Biology
- pharma R&D
- Pharmacology
- Pharmaceutical R&D
- Clinical Evidence
- clinical trials
- Commercialisation & Medical Affairs
- Safety & Toxicology
- patient stratification
- Investment and Market Analysis
- biomarkers
- Translational Science and Biomarkers
- Generics
Night of the Living Drug: The Mortuary of Molecules Has Come Alive!
Read Corpus Healthy Human Protein Atlas Gives AI a Better Map
- Biotech
- Tech and Innovation
- Genetics & Molecular Biology
- Biomedical R&D
- biomarkers
- Translational Science and Biomarkers
- Translational & Pre-clinical Research
- Preclinical Development
- Nonclinical Development
- Research Data
- Research Informatics
- Laboratory Quality
- Multiomics
- Pharma Regulation
- AI & Machine Learning
- AI & Advanced Healthcare
- AI and Automation
- AI Drug Development
- AI Drug Discovery
- Machine Learning in Pharma
- LLMs in Pharma
- Enterprise Validation
- Pharma Intelligence
- pharma R&D
- Pharmaceutical R&D
- HTS and Automation
- Precision Medicine
- Non-Animal Testing
- Computational Biology
- Patient Registries
- Safety & Toxicology
Corpus Healthy Human Protein Atlas Gives AI a Better Map